Analysis of the Asco Value Framework Net Health Benefit Score as A Tool for Assessing Novel Therapies in Relapsed/Refractory Multiple Myeloma (Rrmm)
Abstract
Authors
D Cork L Nelson A Curry
D Cork L Nelson A Curry
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now